TANDem-2: Closing the Gap to Interventions for TAND
TANDem-2: Closing the Gap to Interventions for TAND
Enrolling by invitation · NCT06879665 · Registry updated 2025-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TANDem-2: Closing the Gap to Interventions for TAND | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Malformations of Cortical Development, Group I, Neoplasms, Multiple Primary, central nervous system malformation, cerebral cortical dysplasia, hamartoma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, tuberous sclerosis | Enrolling by invitation | Not applicable | 2025-09-22 | NCT06879665 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| United States Department of Defense | 319 |
| University of Cape Town | 47 |
| Vrije Universiteit Brussel | 74 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| TSC Alliance | Silver Spring | United States | 2 |
| Tuberous Sclerosis Australia | Beverly Hills | Australia | 1 |